FDA 510(k)

ACUVUE OASYS (senofilcon A) mit Photochromischem Zusatz

K-Nummer: K180299 · 2018-04-10

AntragstellerJohnson & Johnson Vision Care, Inc.

Entscheidungsdatum2018-04-10

ProduktcodeLPL

BeratungsausschussOP

EntscheidungSubstantially Equivalent

Produktübersicht

ACUVUE OASYS (senofilcon A) with Photochromic Additive is the device name listed in this FDA 510(k) record. The listed applicant is Johnson & Johnson Vision Care, Inc.. It received FDA 510(k) clearance on 2018-04-10 under 510(k) number K180299. The device is classified under product code LPL. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Häufig gestellte Fragen

What is the ACUVUE OASYS (senofilcon A) with Photochromic Additive?

ACUVUE OASYS (senofilcon A) with Photochromic Additive is a medical device that received FDA 510(k) clearance on 2018-04-10. The listed applicant is Johnson & Johnson Vision Care, Inc.. The 510(k) number is K180299.

When did ACUVUE OASYS (senofilcon A) with Photochromic Additive receive FDA 510(k) clearance?

ACUVUE OASYS (senofilcon A) with Photochromic Additive received FDA 510(k) clearance on 2018-04-10, under 510(k) number K180299.

Who is the listed applicant for ACUVUE OASYS (senofilcon A) with Photochromic Additive?

The FDA 510(k) record lists Johnson & Johnson Vision Care, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ACUVUE OASYS (senofilcon A) with Photochromic Additive?

The FDA product code for ACUVUE OASYS (senofilcon A) with Photochromic Additive is LPL.

Zugehörige klinische Studien

Zugehörige Einträge werden automatisch anhand von Namen, Produktcodes oder anderen Metadaten abgeglichen. Eine Übereinstimmung begründet kein verifiziertes klinisches, wissenschaftliches, unternehmerisches oder regulatorisches Verhältnis; prüfen Sie die verlinkten offiziellen Quellen.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Weitere Einträge mit Johnson & Johnson Vision Care, Inc. als Antragsteller

K210930ACUVUE® OASYS MAX 1-Tages-Kontaktlinsen (senofilcon A)K200243ACUVUE (senofilcon A) Soft Contact Lens Multifocal K160212ACUVUE (senofilcon C) Soft Contact Lens

Verwandte Geräte (Code: LPL)

Offizielle Quelle

In der FDA-Datenbank anzeigen →

Daten aus der FDA Open API. Für die aktuellsten und verbindlichen Informationen konsultieren Sie bitte stets den offiziellen Datensatz.